Stop-smoking help with rewards for people with HIV
Part of Mental health clinical trials.
This study tests a program that helps people with HIV quit smoking by combining medication, counseling, and financial rewards. It aims to see if this approach works well in HIV clinics and helps reduce smoking.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have an HIV diagnosis and receive care at one of the participating clinics.
- You must be 18 years or older.
- You must have smoked at least 100 cigarettes in your lifetime.
- You must currently smoke every day or some days, averaging more than 5 cigarettes per day.
- You cannot be pregnant, nursing, or trying to conceive during the study.
- You must be able to read and understand English or Spanish.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a harm-reduction approach to help people with HIV smoke fewer cigarettes and quit if they want, using an online tobacco program and varenicline (a quit-smoking medicine). You may be placed in one of two different study groups to compare how well the approaches work.
This study tests a mentoring program to help clinicians who care for HIV patients learn more about helping patients quit smoking. It aims to improve how doctors and nurses support tobacco cessation in HIV care.
This study looks at how a specific e-cigarette affects health in people who have HIV and smoke cigarettes regularly. You might be able to join if you meet smoking, HIV care, and safety requirements and are not planning to quit right away.
This trial tests smoking-cessation interventions to help people living with HIV quit smoking or smoke less. You may be eligible if you smoke, are actively engaged in HIV treatment, and can follow the study for about a year.
This study combines a medication to help people stop smoking with a custom mobile app, all within the Swiss HIV Cohort Study. It's designed for people living with HIV who smoke and want to quit.
This study tests a wellness-based smoking-cessation program (including the stop-smoking medicine varenicline) for people living with HIV who want to quit. It aims to help you reduce or stop smoking while monitoring safety, sleep, and mental health during the program.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.